Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Stock Traders Daily
Provider: ValuEngine, Inc.
Provider: Pechala's Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sagent Pharmaceuticals reaffirms FY 2014 revenue guidance - Conference Call

Wednesday, 9 Apr 2014 11:20am EDT 

Sagent Pharmaceuticals Inc:Expects FY 2014 revenue range of $250 mln to $290 mln.FY 2014 revenue of $273 mln - Thomson Reuters I/B/E/S. 

Company Quote

-0.32 -1.40%
4:00pm EDT